199 related articles for article (PubMed ID: 11686010)
1. Thymidylate synthase inhibitors.
Ismail AS; Grem JL
Cancer Chemother Biol Response Modif; 2001; 19():1-19. PubMed ID: 11686010
[No Abstract] [Full Text] [Related]
2. Thymidylate synthase inhibitors.
Ackland SP; Clarke SJ; Beale P; Peters GJ
Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
[No Abstract] [Full Text] [Related]
3. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
Chu E; Callender MA; Farrell MP; Schmitz JC
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase inhibitors in colorectal cancer.
Cassidy J
Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
[No Abstract] [Full Text] [Related]
5. Inhibition of poly(ADP-ribose) polymerase in cancer.
Plummer ER
Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
[TBL] [Abstract][Full Text] [Related]
6. Novel targets for therapy in paediatric oncology.
Estlin EJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):141-50. PubMed ID: 12476788
[TBL] [Abstract][Full Text] [Related]
7. [Oxaliplatin: perspectives and future developments].
Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
[No Abstract] [Full Text] [Related]
8. Promising new agents for treatment of patients with colorectal cancer.
Von Hoff DD
Semin Oncol; 1998 Oct; 25(5 Suppl 11):47-52. PubMed ID: 9786316
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase inhibitors.
Takimoto CH; Diggikar S
Cancer Chemother Biol Response Modif; 2005; 22():1-18. PubMed ID: 16110605
[No Abstract] [Full Text] [Related]
10. Farnesyl transferase inhibitors.
Li T; Sparano JA
Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473
[No Abstract] [Full Text] [Related]
11. Topoisomerase II inhibitors.
Clapp JM; Hande KR
Cancer Chemother Biol Response Modif; 2002; 20():125-49. PubMed ID: 12703203
[No Abstract] [Full Text] [Related]
12. Histone deacetylase inhibitors in cancer therapy.
Fouladi M
Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics, safety, and efficacy of a liposome encapsulated thymidylate synthase inhibitor, OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] in mice.
Desjardins J; Emerson DL; Colagiovanni DB; Abbott E; Brown EN; Drolet DW
J Pharmacol Exp Ther; 2004 Jun; 309(3):894-902. PubMed ID: 14982966
[TBL] [Abstract][Full Text] [Related]
14. Determinants of the therapeutic efficacy of thymidylate synthase inhibitors.
Peters GJ; Kuiper CM; van Triest B; Backus H; van der Wilt CL; van Laar JA; Jansen G; van Groeningen CJ; Pinedo HM
Adv Exp Med Biol; 1998; 431():699-704. PubMed ID: 9598155
[No Abstract] [Full Text] [Related]
15. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
16. Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family.
Ferrari S; Losasso V; Costi MP
ChemMedChem; 2008 Mar; 3(3):392-401. PubMed ID: 18270995
[No Abstract] [Full Text] [Related]
17. Aurora kinases dawn as cancer drug targets.
Sausville EA
Nat Med; 2004 Mar; 10(3):234-5. PubMed ID: 14991042
[No Abstract] [Full Text] [Related]
18. Issues and progress with protein kinase inhibitors for cancer treatment.
Dancey J; Sausville EA
Nat Rev Drug Discov; 2003 Apr; 2(4):296-313. PubMed ID: 12669029
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumors.
Beutel G; Glen H; Schöffski P; Chick J; Gill S; Cassidy J; Twelves C
Clin Cancer Res; 2005 Aug; 11(15):5487-95. PubMed ID: 16061865
[TBL] [Abstract][Full Text] [Related]
20. New targets for cancer chemotherapy.
Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
